FMR LLC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$278,502
-24.7%
80,260
+0.9%
0.00%
Q2 2023$369,721
-52.1%
79,510
-52.4%
0.00%
Q1 2023$772,224
-84.7%
167,148
-73.2%
0.00%
-100.0%
Q4 2022$5,044,619
+21.8%
624,334
-16.4%
0.00%
Q3 2022$4,143,000
+19.7%
746,455
+12.3%
0.00%
Q2 2022$3,462,000
-42.9%
664,411
-9.9%
0.00%
Q1 2022$6,064,000
-44.7%
737,681
+0.1%
0.00%
-100.0%
Q4 2021$10,971,000
-21.2%
737,3000.0%0.00%0.0%
Q3 2021$13,928,000
+1.6%
737,3000.0%0.00%0.0%
Q2 2021$13,706,000
-18.3%
737,3000.0%0.00%0.0%
Q1 2021$16,781,000
+42.3%
737,300
+35.8%
0.00%0.0%
Q4 2020$11,789,000
+246.4%
543,000
+60.4%
0.00%
Q3 2020$3,403,000
+354.3%
338,600
+250.9%
0.00%
Q2 2020$749,000
-23.8%
96,500
+0.1%
0.00%
Q1 2020$983,000
-43.7%
96,403
-39.3%
0.00%
Q4 2019$1,746,000
-13.7%
158,700
-28.7%
0.00%
Q3 2019$2,023,000
-36.0%
222,600
-19.8%
0.00%
Q2 2019$3,159,000
-30.7%
277,572
-30.6%
0.00%
-100.0%
Q1 2019$4,556,000
+26.2%
400,000
-0.1%
0.00%
Q4 2018$3,611,000
-39.8%
400,350
+0.1%
0.00%
-100.0%
Q3 2018$6,000,000400,0000.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders